GEN Exclusives

More »

GEN News Highlights

More »
Jun 1, 2010

GE Healthcare Grants Green Fluorescent Protein Technology Rights to Taconic

  • Taconic inked a deal to use GE Healthcare’s Aequorea victoria green fluorescent protein (AvGFP) in rodent models. The agreement gives Taconic a worldwide, nonexclusive license to use various patented AvGFP variants in the generation and commercialization of genetically modified rodent models.

    Taconic may distribute these models to investigators in pharmaceutical companies, academic institutions, and other research facilities. Taconic may also distribute AvGFP mouse and rat lines generated by academic institutions on a worldwide basis.

    Isolated from jellyfish, AvGFP is intrinsically fluorescent, enabling assays to be conducted without the need for exogenous substrates. Modified AvGFP variants contain patented, performance-enhancing mutations that result in a brighter fluorescence at biological temperatures and offer a range of colors, Taconic explains.

    AvGFP is commonly used as a genetically encoded reporter, allowing investigators to observe gene activity in particular cells or tissues. In combination with specifically applied genetic engineering technologies, AvGFP may also be used to analyze the activity of selected target genes by tagging the proteins that are connected with disease mechanisms in vivo. AvGFP technology also can help to assess and monitor the fate of certain cell types using imaging technology.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »